Open Demat Account
Become a
New
Partner
Financial
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
PMS
TraderX
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
Alternative Investment Funds
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Formulations
Share
Ajanta Pharma Ltd Share Price
Pharmaceuticals - Indian - Formulations
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
2,539.40
2,539.30
Date :
Nov 03,2025 EOD
+74.10
(3.01 )
+3.05
(75.15 )
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
2,483.60
Buy (size)
0.00(x0)
Sell (size)
2,539.40(×187)
Buy Qty
0
Sell Qty
187
Today's High
(₹)
2,557.90
Today's Low
(₹)
2,462.20
52 Week High
(₹)
3,146.70
52 Week Low
(₹)
2,327.30
Market Statistics
Div Yield (%)
1.11
EPS
74.9
Book Value
345.37
Market Cap
31724.9
Face Value
2
Market Lot
1
AGM Date
Jul
Closure Date
ISIN No
INE031B01049
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
82763777
Total of Promoter
82763777
Non Promoter (Institution)
33027213
Non Promoter (Non-Institution)
9144634
Total Non Promoter
42171847
Total Promoter & Non Promoter
124935624
Custodians(Against Depository Receipts)
0
Grand Total
124935624
News
Ajanta Pharma Ltd
Board of Ajanta Pharma recommends interim div..
03-Nov-2025
Read More
Ajanta Pharma Ltd
Board of Ajanta Pharma recommends interim dividend
Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 3 November 2025, inter alia, have recommended the interim dividend of Rs 28 per equity Share (i.e. 1400%) , subject to the approval of the shareholders.
Ajanta Pharma Ltd
Ajanta Pharma consolidated net profit rises 2..
03-Nov-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma consolidated net profit rises 20.19% in the September 2025 quarter
Net profit of Ajanta Pharma rose 20.19% to Rs 260.19 crore in the quarter ended September 2025 as against Rs 216.48 crore during the previous quarter ended September 2024. Sales rose 14.08% to Rs 1353.73 crore in the quarter ended September 2025 as against Rs 1186.64 crore during the previous quarter ended September 2024.
Particulars
Quarter Ended
Sep. 2025
Sep. 2024
% Var.
Sales
1353.73
1186.64
14
OPM %
24.22
26.22
-
PBDT
383.78
324.63
18
PBT
340.81
290.24
17
NP
260.19
216.48
20
Ajanta Pharma Ltd
Ajanta Pharma fixes record date for Dividend
24-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma fixes record date for Dividend
Ajanta Pharma has fixed 10th November 2025 as the record date for the purpose of ascertaining shareholder’s entitlement to Interim Dividend, if any to be declared.
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - R..
24-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - Record Date
Ajanta Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 10-Nov-2025.
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - U..
24-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - Updates
Ajanta Pharma Limited has informed the Exchange regarding Board to consider declaration of 1st Interim Dividend and Record Date Fixation.
Ajanta Pharma Ltd
Ajanta Pharma to announce Quarterly Result
09-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma to announce Quarterly Result
Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 3 November 2025.
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Compliances-Certificate u..
08-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pls find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018.
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Submission Of Sustainabil..
08-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Submission Of Sustainability Report For FY 2025 Prepared As Per GRI Standards
Please find enclosed herewith Sustainability Report for FY 2025 prepared in accordance with the Global Reporting Initiative (GRI) Standards.
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - B..
08-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - Board Meeting Intimation
Ajanta Pharma Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 .
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - A..
08-Oct-2025
Read More
Ajanta Pharma Ltd
Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Ajanta Pharma Limited has informed the Exchange about Schedule of meet
Corporate Details
Board of Directors
Incorporation Year
1979
Chairman
Mannalal B Agrawal
Auditor
B S R & Co LLP
Face Value
2
Market Lot
1
Listing
BSE,MSEI,NSE,
Registered Office
NA     
Contact
Telephone: 91-22-66061000/1204/1203
Fax: 91-22-66061200/1300
Chairman (Non-Executive)
Mannalal B Agrawal
Vice Chairman
Madhusudan B Agrawal
Managing Director
Yogesh Agrawal
Vice President & Company Secretary
Gaurang Shah
Joint Managing Director
Rajesh M Agrawal
Independent Director
David Rasquinha
Medha Joshi
Simi Thapar
Rajesh Shashikant Dalal
Mutual Fund Holdings
1-10
of 137
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
Nippon India Small Cap Fund
402.93
0.61
66,136.11
UTI-Flexi Cap Fund
340.54
1.35
25,187.42
Kotak Small Cap Fund
293.40
1.68
17,480.17
Nippon India Pharma Fund
230.84
2.85
8,113.59
Canara Robeco Large and Mid Cap Fund
223.43
0.88
25,483.99
HDFC Large and Mid Cap Fund
215.90
0.80
26,949.33
UTI-Mid Cap Fund
202.13
1.73
11,666.34
Nippon India Multi Cap Fund
194.30
0.41
47,294.47
Canara Robeco Small Cap Fund
139.33
1.08
12,857.72
PGIM India Midcap Fund
102.19
0.90
11,326.40
FAQ
What is the share price of Ajanta Pharma Ltd today on NSE and BSE?
The Ajanta Pharma Ltd Share price on NSE is Rs.2,539.40 and BSE Rs.2,539.30 as on today
How to buy Ajanta Pharma Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Ajanta Pharma Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Ajanta Pharma Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Ajanta Pharma Ltd is 31724.9
What are the key financial ratios to analyse Ajanta Pharma Ltd Share Price?
Ajanta Pharma Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 33.9
ROE ratio: 26.05
Debt to Equity ratio: 0.01
EPS: 74.9
When did Ajanta Pharma Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Ajanta Pharma Ltd issued bonus shares last in 2022
What is the 52 week highest and lowest share price value of Ajanta Pharma Ltd?
The highest share price value is Rs. 3,146.70 and Lowest share price value is Rs. 2,327.30 for 52 week period for Ajanta Pharma Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Ajanta Pharma Ltd?
Nippon India Small Cap Fund has the highest amount invested with Ajanta Pharma Ltd.
Which year Ajanta Pharma Ltd was incorporated?
Ajanta Pharma Ltd was incorporated in 1979
What is the stock symbol of Ajanta Pharma Ltd?
The stock symbol for Ajanta Pharma Ltd shares is AJANTAPHARMALTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
ABL Bio-Technologies Ltd
526955
Not Listed
ACE Laboratories Ltd
526077
ACELAB
Adline Chem Lab Ltd
524604
Not Listed
Aesculapius Remedies Ltd (Wound-up)
531786
Not Listed
Ahlcon Parenterals (India) Ltd
524448
Not Listed
Alps Laboratories Ltd
526003
Not Listed
American Remedies Ltd (Merged)
531534
Not Listed
Amrutanjan Health Care Ltd
590006
AMRUTANJAN
Ankur Drugs & Pharma Ltd
531683
ANKURDRUGS
Anmol Drugs & Pharmaceuticals Ltd
524778
Not Listed
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
03 Nov 2025
2,07,856.00
52,318.00
25.17
31 Oct 2025
1,02,941.00
74,541.00
72.41
30 Oct 2025
51,967.00
29,957.00
57.65
29 Oct 2025
76,298.00
37,596.00
49.28
28 Oct 2025
56,807.00
38,044.00
66.97
27 Oct 2025
72,406.00
49,516.00
68.39
24 Oct 2025
1,98,793.00
1,57,153.00
79.05
23 Oct 2025
77,041.00
48,695.00
63.21
21 Oct 2025
6,759.00
4,126.00
61.04
20 Oct 2025
51,072.00
33,953.00
66.48
17 Oct 2025
82,681.00
43,611.00
52.75
16 Oct 2025
85,410.00
44,236.00
51.79
15 Oct 2025
1,68,959.00
1,15,833.00
68.56
14 Oct 2025
1,25,928.00
86,268.00
68.51
13 Oct 2025
85,837.00
48,932.00
57.01
10 Oct 2025
1,05,071.00
74,548.00
70.95
09 Oct 2025
2,30,312.00
1,68,047.00
72.96
08 Oct 2025
2,59,490.00
2,05,805.00
79.31
07 Oct 2025
92,147.00
54,099.00
58.71
06 Oct 2025
1,00,950.00
54,918.00
54.40
Please wait ...